Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 410

The DOI matches its Crossref record; 626 of the 626 references it cites were found in a registry or an index.

Signaling pathways in obesity: mechanisms and therapeutic interventions

Open access
Wen, Xue, Zhang, Bohan, Wu, Beiyi, Xiao, Haitao, Li, Zehua, Li, Ruoyu, Xu, Xuewen, Li, Tao·2022·Signal Transduction and Targeted Therapy

Abstract

Obesity is a complex, chronic disease and global public health challenge. Characterized by excessive fat accumulation in the body, obesity sharply increases the risk of several diseases, such as type 2 diabetes, cardiovascular disease, and nonalcoholic fatty liver disease, and is linked to lower life expectancy. Although lifestyle intervention (diet and exercise) has remarkable effects on weight management, achieving long-term success at weight loss is extremely challenging, and the prevalence of obesity continues to rise worldwide. Over the past decades, the pathophysiology of obesity has been extensively investigated, and an increasing number of signal transduction pathways have been implicated in obesity, making it possible to fight obesity in a more effective and precise way. In this review, we summarize recent advances in the pathogenesis of obesity from both experimental and clinical studies, focusing on signaling pathways and their roles in the regulation of food intake, glucose homeostasis, adipogenesis, thermogenesis, and chronic inflammation. We also discuss the current anti-obesity drugs, as well as weight loss compounds in clinical trials, that target these signals. The evolving knowledge of signaling transduction may shed light on the future direction of obesity research, as we move into a new era of precision medicine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41392-022-01149-x

Cites

626 of 626 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 626 references

Research works printed but not linked: 10

  1. Folgueira, C. et al. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway. World J. Gastroenterol. 23, 6403–6411 (2017). · doi:10.3748/wjg.v23.i35.6403
  2. Li-Na, Z. et al. Mesencephalic astrocyte-derived neurotrophic factor and its role in nervous system disease. Neurol. Sci. 38, 1741–1746 (2017). · doi:10.1007/s10072-017-3042-2
  3. Wang, C. et al. Correlation of TLR4 and KLF7 in. Inflamm. Induc. Obes. Inflamm. 40, 42–51 (2017).
  4. McCone, J. Thyroid extract in obesity, with report of a case. Pac. Rec. Med. Sur. 12, 288–289 (1897).
  5. Abbasi, J. Semaglutide’s success could usher in a “new dawn” for obesity treatment. JAMA 326, 121–123 (2021). · doi:10.1001/jama.2021.10307
  6. Harte, R. et al. Topiramate. Practical Diabetes 37, 34–35a (2020). · doi:10.1002/pdi.2258
  7. Basque, J. R. et al. Establishment of culture systems of human gastric epithelium for the study of pepsinogen and gastric lipase synthesis and secretion. Microsc. Res. Tech. 48, 293–302 (2000). · doi:10.1002/(sici)1097-0029(20000301)48:5<293::aid-jemt6>3.0.co;2-a
  8. Aloulou, A. et al. Gastric lipase: an extremophilic interfacial enzyme with medical applications. Cell Mol. Life Sci. 65, 851–854 (2008). · doi:10.1007/s00018-008-7546-z
  9. Bénarouche, A. et al. Using the reversible inhibition of gastric lipase by Orlistat for investigating simultaneously lipase adsorption and substrate hydrolysis at the lipid-water interface. Biochimie 101, 221–231 (2014). · doi:10.1016/j.biochi.2014.01.019
  10. Lüthi-Peng, Q. et al. Identification of the active-site serine in human pancreatic lipase by chemical modification with tetrahydrolipstatin. FEBS Lett. 299, 111–115 (1992). · doi:10.1016/0014-5793(92)80112-t

Cited by

See all 410

Metadata

Authors
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T.
Venue
Signal Transduction and Targeted Therapy
Published
2022-08-28
Volume
7
Issue
1
Pages
298-298
ISSN
2059-3635 (ISSN-L)
OpenAlex
W4293515528
Cited by
410
References
626
FWCI
32.82
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Signaling pathways in obesity: mechanisms and therapeutic interventions. https://app.cochat.ai/papers/10.1038/s41392-022-01149-x
The paper
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022). Signaling pathways in obesity: mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-022-01149-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.